ANO1 and central nervous system cancer: In some cancer types, such as glioma, head and neck squamous cell carcinoma (HNSCC), colorectal cancer, and prostate carcinoma, inhibition of ANO1 promoted not only reduction of tumor size and cell proliferation [24], but also decrease in migration, invasion, and metastasis [25,26,27].